ENTITY
Remegen

Remegen (9995 HK)

204
Analysis
Health CareChina
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
more
bullishRemegen
13 Aug 2020 10:04

RemeGen (荣昌生物) Pre-IPO: Thoughts on Valuation of RC18 and RC48

RemeGen is a China-based commercial-ready biopharmaceutical company with a focus on first-in-class and best-in-class biologics in the area of...

Logo
715 Views
Share
bullishRemegen
30 Jul 2020 16:29

RemeGen (荣昌生物) Pre-IPO: Top-Notch R&D Capability and a Strong Team

RemeGen is a China-based commercial-ready biopharmaceutical company with a focus on first-in-class and best-in-class biologics in the area of...

Logo
538 Views
Share
17 Sep 2023 10:10

A-H Premium Weekly (Sep 15th): Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec Oilfield

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec...

Logo
453 Views
Share
x